NPT
MRK icon

Nixon Peabody Trust’s Merck MRK Stock Holding History

Nixon Peabody Trust’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10M Sell
77,974
-733
-0.9% -$85.8K 0.71% 46
2026
Q1 		$9.47M Sell
78,707
-1,390
-2% -$160K 0.75% 46
2025
Q4 		$8.43M Sell
80,097
-182
-0.2% -$17.1K 0.64% 46
2025
Q3 		$6.74M Sell
80,279
-851
-1% -$70.1K 0.49% 56
2025
Q2 		$6.42M Sell
81,130
-887
-1% -$70.5K 0.5% 54
2025
Q1 		$7.36M Sell
82,017
-1,993
-2% -$186K 0.63% 49
2024
Q4 		$8.36M Buy
84,010
+1,801
+2% +$186K 0.69% 43
2024
Q3 		$9.34M Sell
82,209
-352
-0.4% -$41.8K 0.78% 48
2024
Q2 		$10.2M Buy
82,561
+11,944
+17% +$1.54M 0.91% 42
2024
Q1 		$9.32M Buy
70,617
+2,327
+3% +$287K 0.86% 48
2023
Q4 		$7.44M Buy
68,290
+65,815
+2,659% +$6.83M 0.83% 48
2023
Q3 		$255K Sell
2,475
-495
-17% -$53.4K 0.21% 68
2023
Q2 		$343K Hold
2,970
– – 0.28% 63
2023
Q1 		$316K Sell
2,970
-1,967
-40% -$212K 0.22% 57
2022
Q4 		$548K Buy
4,937
+42
+0.9% +$4.29K 0.44% 55
2022
Q3 		$422K Sell
4,895
-44,954
-90% -$4.01M 0.36% 58
2022
Q2 		$4.54M Sell
49,849
-600
-1% -$53.2K 2.05% 13
2022
Q1 		$4.14M Sell
50,449
-2,325
-4% -$183K 1.42% 33
2021
Q4 		$4.04M Buy
52,774
+22,488
+74% +$1.79M 1.22% 40
2021
Q3 		$2.27M Buy
30,286
+2,475
+9% +$188K 0.82% 46
2021
Q2 		$2.16M Sell
27,811
-1,438
-5% -$107K 0.83% 46
2021
Q1 		$2.15M Buy
29,249
+336
+1% +$24.8K 0.87% 46
2020
Q4 		$2.26M Buy
28,913
+20,837
+258% +$1.59M 0.95% 45
2020
Q3 		$639K Hold
8,076
– – 0.29% 56
2020
Q2 		$596K Sell
8,076
-267
-3% -$20.1K 0.3% 56
2020
Q1 		$613K Buy
8,343
+1,697
+26% +$133K 0.38% 52
2019
Q4 		$577K Sell
6,646
-2,788
-30% -$229K 0.29% 57
2019
Q3 		$758K Sell
9,434
-4,522
-32% -$362K 0.4% 52
2019
Q2 		$1.12M Buy
13,956
+1,624
+13% +$124K 0.63% 46
2019
Q1 		$979K Sell
12,332
-1,683
-12% -$126K 0.64% 48
2018
Q4 		$1.02M Buy
14,015
+412
+3% +$29.1K 0.8% 48
2018
Q3 		$921K Buy
13,603
+1,000
+8% +$63.7K 0.63% 51
2018
Q2 		$730K Buy
12,603
+269
+2% +$15.2K 0.57% 52
2018
Q1 		$641K Sell
12,334
-157
-1% -$8.48K 0.57% 50
2017
Q4 		$671K Sell
12,491
-210
-2% -$11.6K 0.58% 50
2017
Q3 		$776K Sell
12,701
-419
-3% -$25.4K 0.7% 49
2017
Q2 		$803K Buy
13,120
+210
+2% +$12.8K 0.74% 48
2017
Q1 		$783K Hold
12,910
– – 0.74% 49
2016
Q4 		$725K Sell
12,910
-2,096
-14% -$123K 0.71% 49
2016
Q3 		$894K Sell
15,006
-6,305
-30% -$369K 0.88% 46
2016
Q2 		$1.17M Sell
21,311
-236
-1% -$12.6K 1.02% 41
2016
Q1 		$1.09M Hold
21,547
– – 0.97% 41
2015
Q4 		$1.09M Buy
+21,547
New +$1.09M 0.99% 37

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Nixon Peabody Trust's MRK Position: Q2 2026 in Review

Nixon Peabody Trust reduced its Merck (MRK) stake by 0.93% in Q2 2026, selling an estimated $85.8K and leaving 77,974 shares worth $10M. The position accounts for 0.71% of the portfolio, ranked #46.

Nixon Peabody Trust first reported a position in MRK in Q4 2015 and has held it in 43 quarters since. The position peaked at $10.2M in Q2 2024. 1,598 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Nixon Peabody Trust held 77,974 shares of Merck worth $10M as of Q2 2026.
  • Nixon Peabody Trust sold 733 Merck shares in Q2 2026, an estimated $85.8K.
  • Merck made up 0.71% of Nixon Peabody Trust's portfolio in Q2 2026, its #46 holding.
  • Nixon Peabody Trust first reported a position in Merck in Q4 2015 and has held it in 43 quarters since.
  • Nixon Peabody Trust's Merck position peaked at $10.2M in Q2 2024.
  • 1,598 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.